- m-PEG4-SH
-
- $33.00 / 25mg
-
2024-11-19
- CAS:52190-55-3
- Min. Order:
- Purity: ≥98%
- Supply Ability: 10g
- M-PEG4-SH
-
- $0.00 / 1g
-
2024-03-27
- CAS:52190-55-3
- Min. Order: 1g
- Purity: >98.00%
- Supply Ability: 1g
|
| 2,5,8,11-TETRAOXATRIDECANE-13-THIOL Basic information |
Product Name: | 2,5,8,11-TETRAOXATRIDECANE-13-THIOL | Synonyms: | 2,5,8,11-TETRAOXATRIDECANE-13-THIOL;MPEG4-SH;MPEG4-HS;m-PEG4-thiol;mPEG4-HS;m-dPEG??-Thiol;2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethanethiol;Thiol-PEG4-methyl | CAS: | 52190-55-3 | MF: | C9H20O4S | MW: | 224.32 | EINECS: | 203-324-2 | Product Categories: | peg | Mol File: | 52190-55-3.mol |  |
| 2,5,8,11-TETRAOXATRIDECANE-13-THIOL Chemical Properties |
Boiling point | 84 °C(Press: 1 Torr) | density | 1.035 | storage temp. | Inert atmosphere,Room Temperature | solubility | Chloroform (Slightly), Methanol (Slightly) | pka | 9?+-.0.10(Predicted) | form | Liquid | color | Colorless to light yellow | Stability: | Air Sensitive |
| 2,5,8,11-TETRAOXATRIDECANE-13-THIOL Usage And Synthesis |
Uses | m-PEG4-SH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | IC 50 | PEGs | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| 2,5,8,11-TETRAOXATRIDECANE-13-THIOL Preparation Products And Raw materials |
|